GeneDx Holdings Corp. Payments to Develop Software
GeneDx Holdings Corp. (WGS) reported Payments to Develop Software of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToDevelopSoftware · last filed 2026-02-23
- GeneDx Holdings Corp. payments to develop software for the quarter ending 2024-12-31 was $0.00.
- GeneDx Holdings Corp. payments to develop software for the quarter ending 2024-09-30 was $0.00.
- GeneDx Holdings Corp. payments to develop software for the quarter ending 2024-06-30 was $0.00.
- GeneDx Holdings Corp. payments to develop software for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- GeneDx Holdings Corp. payments to develop software for fiscal 2025 was $0.00.
- GeneDx Holdings Corp. payments to develop software for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- GeneDx Holdings Corp. payments to develop software for fiscal 2023 was $461.00K, a 93.57% decline from fiscal 2022.
- GeneDx Holdings Corp. payments to develop software for fiscal 2022 was $7.17M, a 37.06% decline from fiscal 2021.
| Period end | Payments to Develop Software 3 month | Payments to Develop Software 6 month | Payments to Develop Software 9 month | Payments to Develop Software 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-23 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $0.00 derived: sum of 3 quarters · filed 2026-02-23 | $0.00 10-K · filed 2026-02-23 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $0.00 derived: sum of 2 quarters · filed 2024-10-29 | $0.00 10-Q · filed 2024-10-29 | $0.00 derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $0.00 10-Q · filed 2024-07-30 | $0.00 derived: sum of 3 quarters · filed 2026-02-23 | $0.00 derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $0.00 10-Q · filed 2024-04-29 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $0.00 derived: sum of 3 quarters · filed 2026-02-23 | -$1.00K derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | -$1.00K derived: sum of 3 quarters · filed 2026-02-23 | $461.00K 10-K · filed 2026-02-23 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | -$1.00K derived: sum of 2 quarters · filed 2024-10-29 | $461.00K 10-Q · filed 2024-10-29 | $1.13M derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $461.00K 10-Q · filed 2024-07-30 | $1.13M derived: sum of 3 quarters · filed 2024-07-30 | $3.17M derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | $462.00K 10-Q · filed 2024-04-29 | $1.13M derived: sum of 2 quarters · filed 2024-04-29 | $3.17M derived: sum of 3 quarters · filed 2024-04-29 | $5.09M derived: sum of 4 quarters · filed 2024-04-29 |
| 2022-12-31 | $672.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $2.71M derived: sum of 2 quarters · filed 2024-02-23 | $4.63M derived: sum of 3 quarters · filed 2024-02-23 | $7.17M 10-K · filed 2024-02-23 |
| 2022-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $3.96M derived: sum of 2 quarters · filed 2023-11-03 | $6.49M 10-Q · filed 2023-11-03 | $9.13M derived: sum of 4 quarters · filed 2023-11-03 |
| 2022-06-30 | $1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $4.46M 10-Q · filed 2023-08-08 | $7.09M derived: sum of 3 quarters · filed 2023-08-08 | $9.69M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $2.54M 10-Q · filed 2023-05-09 | $5.17M derived: sum of 2 quarters · filed 2023-05-09 | $7.77M derived: sum of 3 quarters · filed 2023-05-09 | $11.00M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $5.23M derived: sum of 2 quarters · filed 2023-03-16 | $8.47M derived: sum of 3 quarters · filed 2023-03-16 | $11.39M 10-K · filed 2023-03-16 |
| 2021-09-30 | $2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $5.83M derived: sum of 2 quarters · filed 2022-11-14 | $8.75M 10-Q · filed 2022-11-14 | $13.46M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $3.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $6.16M 10-Q · filed 2022-08-15 | $10.87M derived: sum of 3 quarters · filed 2023-03-16 | |
| 2021-03-31 | $2.92M 10-Q · filed 2022-05-12 | $7.63M derived: sum of 2 quarters · filed 2023-03-16 | ||
| 2020-12-31 | $4.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $7.88M 10-K · filed 2023-03-16 | ||
| 2020-09-30 | $3.17M 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $3.53M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |